48.40
0.92%
-0.45
After Hours:
48.40
Radnet Inc stock is currently priced at $48.40, with a 24-hour trading volume of 285.82K.
It has seen a -0.92% decreased in the last 24 hours and a +0.19% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $48.40 pivot point. If it approaches the $49.43 resistance level, significant changes may occur.
Previous Close:
$48.85
Open:
$48.72
24h Volume:
285.82K
Market Cap:
$3.57B
Revenue:
$1.62B
Net Income/Loss:
$3.04M
P/E Ratio:
-193.60
EPS:
-0.25
Net Cash Flow:
$33.35M
1W Performance:
+4.04%
1M Performance:
+0.19%
6M Performance:
+88.40%
1Y Performance:
+77.42%
Radnet Inc Stock (RDNT) Company Profile
Name
Radnet Inc
Sector
Industry
Phone
310-478-7808
Address
1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA
Radnet Inc Stock (RDNT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-31-23 | Initiated | Truist | Buy |
Mar-31-23 | Initiated | CJS Securities | Market Outperform |
Mar-03-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
Aug-12-21 | Initiated | Barclays | Overweight |
Mar-15-19 | Downgrade | Raymond James | Strong Buy → Outperform |
Mar-14-18 | Initiated | Raymond James | Strong Buy |
Aug-22-17 | Upgrade | Jefferies | Hold → Buy |
Jun-02-16 | Initiated | Sterne Agee CRT | Neutral |
Apr-15-16 | Initiated | Sidoti | Buy |
Mar-17-09 | Reiterated | Jefferies & Co | Buy |
Oct-15-08 | Initiated | RBC Capital Mkts | Sector Perform |
Jul-14-08 | Upgrade | Stanford Research | Hold → Buy |
Apr-02-08 | Upgrade | Morgan Keegan | Mkt Perform → Outperform |
Mar-14-08 | Downgrade | Morgan Keegan | Outperform → Mkt Perform |
Dec-19-07 | Initiated | Leerink Swann | Outperform |
Dec-07-07 | Initiated | Stanford Research | Hold |
Nov-07-07 | Initiated | Morgan Keegan | Outperform |
Oct-19-07 | Initiated | Deutsche Securities | Buy |
Jun-18-07 | Reiterated | Jefferies & Co | Buy |
May-22-07 | Initiated | Jefferies & Co | Buy |
View All
Radnet Inc Stock (RDNT) Latest News
RadNet, Inc. Announces Date of its First Quarter 2024 Financial Results Conference Call
GlobeNewswire Inc.
RadNet Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction
GlobeNewswire Inc.
RadNet’s Delaware Imaging Network Announces Ribbon-Cutting Ceremony for Mammography Service at Milford Walmart
GlobeNewswire Inc.
RadNet Teams Up with Basketball Icon Sheryl Swoopes to Promote Healthcare Equity and Access
GlobeNewswire Inc.
RadNet Announces Pricing and Upsizing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction
GlobeNewswire Inc.
RadNet to Make its Second Acquisition in Houston, Texas
GlobeNewswire Inc.
Radnet Inc Stock (RDNT) Financials Data
Radnet Inc (RDNT) Revenue 2024
RDNT reported a revenue (TTM) of $1.62 billion for the quarter ending December 31, 2023, a +13.05% rise year-over-year.
Radnet Inc (RDNT) Net Income 2024
RDNT net income (TTM) was $3.04 million for the quarter ending December 31, 2023, a -71.42% decrease year-over-year.
Radnet Inc (RDNT) Cash Flow 2024
RDNT recorded a free cash flow (TTM) of $33.34 million for the quarter ending December 31, 2023, a +132.38% increase year-over-year.
Radnet Inc (RDNT) Earnings per Share 2024
RDNT earnings per share (TTM) was -$0.02 for the quarter ending December 31, 2023, a -111.76% decline year-over-year.
About Radnet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. As of December 31, 2017, it operated 297 facilities directly or indirectly through joint ventures with hospitals in California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Cap:
|
Volume (24h):